Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07HSQ
|
|||
Former ID |
DNC007096
|
|||
Drug Name |
1-adamantan-1-yl-3-((R)-1-phenyl-ethyl)-urea
|
|||
Synonyms |
CHEMBL222080; 1-adamantan-1-yl-3-((R)-1-phenyl-ethyl)-urea
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C19H26N2O
|
|||
Canonical SMILES |
CC(C1=CC=CC=C1)NC(=O)NC23CC4CC(C2)CC(C4)C3
|
|||
InChI |
1S/C19H26N2O/c1-13(17-5-3-2-4-6-17)20-18(22)21-19-10-14-7-15(11-19)9-16(8-14)12-19/h2-6,13-16H,7-12H2,1H3,(H2,20,21,22)/t13-,14?,15?,16?,19?/m1/s1
|
|||
InChIKey |
ODVZFEPLOWORBJ-PGBRGIIUSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Soluble epoxide hydrolase (EPHX2) | Target Info | Inhibitor | [1] |
KEGG Pathway | Arachidonic acid metabolism | |||
Metabolic pathways | ||||
Peroxisome | ||||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
WikiPathways | Metapathway biotransformation | |||
Arachidonate Epoxygenase / Epoxide Hydrolase | ||||
Arachidonic acid metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors. Bioorg Med Chem Lett. 2006 Nov 15;16(22):5773-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.